当前位置:首页 - 行情中心 - 鸿仕达(920125) - 财务分析 - 利润表

鸿仕达

(920125)

  

流通市值:0.00万  总市值:0.00万
流通股本:0.00万   总股本:0.00万

利润表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
一、营业总收入664,303,686.04388,441,877.15196,377,756.9792,992,915.34
  营业收入664,303,686.04388,441,877.15196,377,756.9792,992,915.34
二、营业总成本578,043,053.46361,034,757.12198,918,030.2198,861,736.41
  营业成本457,223,299.39276,536,364.71145,062,196.7773,396,662.78
  税金及附加5,108,296.542,609,641.951,510,606.45989,934.21
  销售费用28,309,792.6518,506,821.6912,271,601.745,344,859.95
  管理费用26,040,880.0518,412,813.1211,740,090.115,775,324.57
  研发费用58,014,063.743,493,674.8727,756,112.6213,376,158.5
  财务费用3,346,721.131,475,440.78577,422.52-21,203.6
  其中:利息费用3,616,643.532,713,046.011,765,760.79815,526.62
  其中:利息收入1,871,093.371,725,141.971,265,330.35785,445.26
三、其他经营收益
  加:投资收益3,796,988.473,578,526.673,562,389.683,562,389.68
  资产处置收益142,147.96142,147.96142,147.96142,147.96
  资产减值损失(新)-19,138,874.72-11,433,200.85-8,016,342.74-4,433,833.77
  信用减值损失(新)-7,693,696.883,561,746.15,232,071.45230,573.65
  其他收益11,810,072.94,429,245.484,074,886.472,140,494.46
四、营业利润75,177,270.3127,685,585.392,454,879.58-4,227,049.09
  加:营业外收入15,769.2115,769.2115,758.113,716.81
  减:营业外支出130,766.44121,07995,021.831,500
五、利润总额75,062,273.0827,580,275.62,375,615.89-4,254,832.28
  减:所得税费用4,582,294.29-1,355,132.23-3,332,525.71-2,456,574.23
六、净利润70,479,978.7928,935,407.835,708,141.6-1,798,258.05
(一)按经营持续性分类
  持续经营净利润70,479,978.7928,935,407.835,708,141.6-1,798,258.05
(二)按所有权归属分类
  归属于母公司股东的净利润69,751,365.1629,201,543.85,545,145.14-1,472,515.54
  少数股东损益728,613.63-266,135.97162,996.46-325,742.51
  扣除非经常损益后的净利润62,080,243.2524,664,745.861,308,045.14-6,072,808.49
七、每股收益
  (一)基本每股收益1.640.680.13-0.03
  (二)稀释每股收益1.640.680.13-0.03
八、其他综合收益22,230.72---
  归属于母公司股东的其他综合收益22,230.72---
九、综合收益总额70,502,209.5128,935,407.835,708,141.6-1,798,258.05
  归属于母公司股东的综合收益总额69,773,595.8829,201,543.85,545,145.14-1,472,515.54
  归属于少数股东的综合收益总额728,613.63-266,135.97162,996.46-325,742.51
公告日期2026-01-212025-12-182025-08-272025-06-19
审计意见(境内)标准无保留意见标准无保留意见
TOP↑